LQDA
Liquidia Technologies IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$5.42B
P/E Ratio
358.71
EPS
$0.17
Beta
0.42
52W High
$62.30
52W Low
$11.85
50-Day MA
$42.08
200-Day MA
$33.44
Dividend Yield
—
Profit Margin
7.74%
Forward P/E
29.41
PEG Ratio
—
About Liquidia Technologies Inc
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and markets various products for the unmet needs of patients in the United States. The company is headquartered in Morrisville, North Carolina.
Fundamentals
| Revenue (TTM) | $288.06M |
| Gross Profit (TTM) | $264.49M |
| EBITDA | $46.63M |
| Operating Margin | 46.30% |
| Return on Equity | 28.20% |
| Return on Assets | 9.05% |
| Revenue/Share (TTM) | $3.32 |
| Book Value | $1.23 |
| Price-to-Book | 49.94 |
| Price-to-Sales (TTM) | 18.82 |
| EV/Revenue | 18.69 |
| EV/EBITDA | 100.10 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 4159.00% |
| Shares Outstanding | $88.93M |
| Float | $62.19M |
| % Insiders | 12.69% |
| % Institutions | 70.12% |
Historical Volatility
HV 10-Day
117.36%
HV 20-Day
86.57%
HV 30-Day
78.25%
HV 60-Day
66.69%
HV Rank
81.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($65.12 target)
1
Strong Buy7
Buy1
SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026